127 related articles for article (PubMed ID: 12480918)
1. (-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface.
Dell'Aica I; Donà M; Sartor L; Pezzato E; Garbisa S
Lab Invest; 2002 Dec; 82(12):1685-93. PubMed ID: 12480918
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
Annabi B; Lachambre MP; Bousquet-Gagnon N; Page M; Gingras D; Beliveau R
Biochim Biophys Acta; 2002 Jan; 1542(1-3):209-20. PubMed ID: 11853893
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP.
Oku N; Matsukawa M; Yamakawa S; Asai T; Yahara S; Hashimoto F; Akizawa T
Biol Pharm Bull; 2003 Sep; 26(9):1235-8. PubMed ID: 12951464
[TBL] [Abstract][Full Text] [Related]
4. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.
El Bedoui J; Oak MH; Anglard P; Schini-Kerth VB
Cardiovasc Res; 2005 Aug; 67(2):317-25. PubMed ID: 15885676
[TBL] [Abstract][Full Text] [Related]
5. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
[TBL] [Abstract][Full Text] [Related]
6. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
Garbisa S; Sartor L; Biggin S; Salvato B; Benelli R; Albini A
Cancer; 2001 Feb; 91(4):822-32. PubMed ID: 11241252
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate.
Pezzato E; Donà M; Sartor L; Dell'Aica I; Benelli R; Albini A; Garbisa S
J Leukoc Biol; 2003 Jul; 74(1):88-94. PubMed ID: 12832446
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation.
Zhen MC; Huang XH; Wang Q; Sun K; Liu YJ; Li W; Zhang LJ; Cao LQ; Chen XL
Acta Pharmacol Sin; 2006 Dec; 27(12):1600-7. PubMed ID: 17112415
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.
Zgheib A; Lamy S; Annabi B
J Biol Chem; 2013 May; 288(19):13378-86. PubMed ID: 23548906
[TBL] [Abstract][Full Text] [Related]
12. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
[TBL] [Abstract][Full Text] [Related]
14. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
16. Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors.
Djerir D; Iddir M; Bourgault S; Lamy S; Annabi B
Biophys Chem; 2018 Mar; 234():34-41. PubMed ID: 29407769
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.
Sen T; Moulik S; Dutta A; Choudhury PR; Banerji A; Das S; Roy M; Chatterjee A
Life Sci; 2009 Feb; 84(7-8):194-204. PubMed ID: 19105967
[TBL] [Abstract][Full Text] [Related]
18. CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.
Lee HM; Golub LM; Cao J; Teronen O; Laitinen M; Salo T; Zucker S; Sorsa T
Curr Med Chem; 2001 Feb; 8(3):257-60. PubMed ID: 11172680
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane-associated MT1-MMP-dependent activation of pro-MMP-2 in A375 melanoma cells.
Banerji A; Chakraborti J; Mitra A; Chatterjee A
J Environ Pathol Toxicol Oncol; 2005; 24(1):3-17. PubMed ID: 15715505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
